Results 91 to 100 of about 19,245,256 (145)

Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma. [PDF]

Front Oncol
Amaducci E, Clerico M, Camoirano D, Marinucci C, Giaccone L, Dogliotti I, Dicataldo M, D'Agostino M, Bruno B, Cavallo F.   +9 more
europepmc   +1 more source

Engineered mesenchymal stem cell-derived extracellular vesicles as programmable biomaterial platforms for liver fibrosis: design principles, manufacturing and clinical translation. [PDF]

Front Bioeng Biotechnol
Wang F, Zhu K, Zhu X, Yao J, Sun Z, Li X.   +5 more
europepmc   +1 more source

Engineering Lung-on-a-chip microdevices for respiratory disease modelling and drug testing: A fit-for-purpose framework for design and translational validation. [PDF]

Biomed Microdevices
Cheong SY, Liew TIZ, Wong CK, Teng XX, Cha XY, Ng NC, Wong RS, Goh BH.   +7 more
europepmc   +1 more source

iPSC-derived CAR-NK extracellular vesicles for non-small cell lung cancer: evidence, engineering, and translational barriers. [PDF]

Front Immunol
Liang Z, Zhao X, Jiang M, Zhou M, Liu S, Zhao Y.   +5 more
europepmc   +1 more source

Regenerative extracellular vesicles reshape systemic aging: lessons from antler stem cells. [PDF]

Int J Biol Sci
Lee SJ, Bae J, Cheon YJ, Kim EK.
europepmc   +1 more source

Manufacturing, Cell Regulation, and Coculture Strategies for Vascularization and Neural Innervation of Skeletal Muscle Tissue. [PDF]

Adv Healthc Mater
Wang Z, He X, Zhong S, Liu J, Shi Z, Yin R, Liu Y.   +6 more
europepmc   +1 more source

The carbon footprint of Chimeric Antigen Receptor-T cell manufacturing processes. [PDF]

Int J Pharm X
van der Bijl WE, Gareb B, Klomberg KM, Bremer E, van Meerten T, Oude Munnink TH, Dekkers BGJ.   +6 more
europepmc   +1 more source

A proposal of good manufacturing practices (GMP) laboratory for CAR T-cell therapy in Latin America and the Caribbean: challenges and opportunities. [PDF]

Front Public Health
Cabrera-Salcedo SC, Parra-Lara LG, Fernandes-Pineda M, Toro-Pedroza A, Hincapie JSV, Rios-Serna LJ, Loukanov A, Ortiz-Guzman J, Garcia-Robledo JE, Cañas CA, Cruz-Suarez GA, Osorio FO, Gustafson MP, Restrepo JG, Mosquera A, Hoyos V, Baena JC.   +16 more
europepmc   +1 more source

Predicting ACI Outcomes with GMP In-Process Control Kinetic Metrics: Initial Chondrocyte Yield and Population Doubling Time as Prognostic Clinical Biomarkers. [PDF]

Life (Basel)
Philippe V, Laurent AE, Berchtold A, Hirt-Burri N, Applegate LA, Martin R.   +5 more
europepmc   +1 more source

Solving a mathematical model integrating unequal-area facilities layout and part scheduling in a cellular manufacturing system by a genetic algorithm. [PDF]

Springerplus, 2016
Ebrahimi A, Kia R, Komijan AR.
europepmc   +1 more source